TEL AVIV, Israel and PARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of executive management will present at three upcoming investor conferences as follows:
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on Wednesday, December 2, 2026 at 8:20am ET and members of management will be available for 1x1 meetin.
NEW HAVEN, Conn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that senior management will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on November 30, 2026 at 12:55 PM EST.
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced that it will attend the 9th Annual Evercore Healthcare Conference in Miami, FL on Tuesday, December 1, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer, and Megan Carlson, SVP, Accounting & Finance - Chief Accounting Officer wi.
Cost discipline is widening margins faster than revenue grows, a rare dynamic that could fuel shareholder returns.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors need to pay close attention to EVR stock based on the movements in the options market lately.
SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference in Miami on Tuesday, December 1, 2026, at 2:10 p.m.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Evercore's prior buy rating is reaffirmed. Bullish view on EVR driven by solid Q3 results, low leverage risk, and performance vs. similar peers. The dividend is well covered as of this writing.